[PLX] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 37.92%
YoY- 84.11%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 27,018 663 2,006 4,553 2,469 7,526 6,358 161.66%
PBT 9,781 -15,544 -11,294 -9,400 -15,141 -11,437 450 674.48%
Tax 99 230 75 132 916 8 3,045 -89.74%
NP 9,781 -15,544 -11,294 -9,400 -15,141 -11,437 450 674.48%
Tax Rate -1.01% - - - - - -676.67% -
Total Cost 17,237 16,207 13,300 13,953 17,610 18,963 5,908 103.78%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 36.20 -2,344.49 -563.01 -206.46 -613.24 -151.97 7.08 195.90%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS 0.66 -1.05 -0.77 -0.65 -1.08 -0.86 0.04 544.81%
EPS Diluted 0.66 -1.05 -0.77 -0.65 -1.04 -0.86 -0.60 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.